Version 2.77

Description

Clorazepate (marketed under the brand names Tranxene® and Tranxilium®) is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Clorazepate has been discontinued since February 2006 in the UK. Indications:Clorazepate is used in the treatment of anxiety disorders and insomnia. It may also be prescribed as an anticonvulsant or muscle relaxant. Clorazepate is principally prescribed in the treatment of alcohol withdrawal and epilepsy, although it is also a useful anxiolytic because of its long half-life. The normal starting dosage range of clorazepate is 15-60 mg 2-4 x per day. Dosages as high as 90-120 mg per day may be used in the treatment of acute alcohol withdrawal. Clorazepate is available in 3.75, 7.5, and 15 mg capsules or tablets. Clorazepate SD (controlled release) is available in 11.25 and 22.5 mg tablets. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Clorazepate (Wikipedia)

Basic Part Properties

Part Display Name
Clorazepate
Part Type
Component (Describes the core component or analyte measured)
Created On
2000-05-04
Construct for LOINC Short Name
Clorazepate

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP16088-4
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP16088-4

Language Variants Get Info

Tag Language Translation
zh-CN Chinese (China) 氯氮
fr-CA French (Canada) Clorazépate
et-EE Estonian (Estonia) Klorasepaat
es-ES Spanish (Spain) Clorazepato
it-IT Italian (Italy) Clorazepato
tr-TR Turkish (Turkey) Klorazepat
ru-RU Russian (Russian Federation) Клоразепат
nl-NL Dutch (Netherlands) clorazepaat
fr-BE French (Belgium) Clorazépate